Company / Free Cash Flow per Share
Medpace Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$22.26
FY2025
5-year range
$6.31 / $22.26
FY2021-FY2025
Trend
+19.6%
vs FY2024
Sector context
#5 of 148
Health Care
What the data says
Among 148 Health Care companies, Medpace is in the top 3% for free cash flow per share. Free Cash Flow per Share has increased for 3 consecutive years, from $6.31 in FY2022 to $22.26 in FY2025.
Based on SEC 10-K filings.
22.26 in FY2025 with a 5-year CAGR of +28.7%. Top quartile in the Health Care sector.
Improved from $12.76 to $22.26 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +52.2%
- 5-Year CAGR
- +28.7%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 148This company $22.26 Sector average $5.04
▼
+341.4% above sector average
Key checks
Key Insights
- Medpace's free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 19.6% year-over-year.
- Ranks #5 out of 148 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 147.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $22.26 | +19.6% |
| FY2024 | $18.61 | +45.8% |
| FY2023 | $12.76 | +102.1% |
| FY2022 | $6.31 | -4.6% |
| FY2021 | $6.62 | +5.0% |
| FY2020 | $6.30 | +22.2% |
| FY2019 | $5.16 | +133.9% |
| FY2018 | $2.20 | +4.7% |
| FY2017 | $2.11 | -12.1% |
| FY2016 | $2.40 | -5.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026